We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.97%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$83.2B
AUM Growth
+$1.08B
Cap. Flow
-$819M
Cap. Flow %
-0.99%
Top 10 Hldgs %
34.54%
Holding
3,151
New
709
Increased
920
Reduced
837
Closed
626

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.06B
2
UNH icon
UnitedHealth
UNH
+$935M
3
UBER icon
Uber
UBER
+$426M
4
BA icon
Boeing
BA
+$312M
5
CRM icon
Salesforce
CRM
+$309M

Sector Composition

Rank Sector Weight
1 Technology 20.14%
2 Consumer Discretionary 14.92%
3 Healthcare 12.54%
4 Financials 8.46%
5 Industrials 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAN icon
1301
ManpowerGroup
MAN
$2.5B
$2.63M ﹤0.01%
+45,600
New +$2.9M
SIMO icon
1302
Silicon Motion
SIMO
$8.29B
$2.63M ﹤0.01%
48,667
-67,627
-58% -$3.79M
JOE icon
1303
St. Joe Company
JOE
$3.56B
$2.63M ﹤0.01%
+58,494
New +$3.03M
LFST icon
1304
Lifestance Health
LFST
$4.15B
$2.62M ﹤0.01%
+355,924
New +$2.55M
LWAY icon
1305
Lifeway Foods
LWAY
$466M
$2.62M ﹤0.01%
105,589
-62,336
-37% -$1.56M
ERII icon
1306
Energy Recovery
ERII
$439M
$2.61M ﹤0.01%
+177,630
New +$3.04M
FMC icon
1307
FMC
FMC
$1.39B
$2.59M ﹤0.01%
+53,303
New +$3.11M
OFIX icon
1308
Orthofix Medical
OFIX
$481M
$2.58M ﹤0.01%
148,043
-13,993
-9% -$243K
CATX icon
1309
Perspective Therapeutics
CATX
$322M
$2.57M ﹤0.01%
807,172
-683,619
-46% -$5.58M
ROG icon
1310
Rogers Corp
ROG
$2.31B
$2.57M ﹤0.01%
25,315
-16,685
-40% -$1.74M
AD
1311
Array Digital Infrastructure
AD
$2.99B
$2.57M ﹤0.01%
+40,963
New +$2.5M
FEZ icon
1312
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.32B
$2.57M ﹤0.01%
53,317
+18,766
+54% +$935K
QQQ icon
1313
Invesco QQQ Trust
QQQ
$449B
$2.56M ﹤0.01%
5,000
-3,697
-43% -$1.87M
WMT icon
1314
CALL
Walmart Inc
WMT
$889B
$2.55M ﹤0.01%
+28,200
New +$2.45M
CENT icon
1315
Central Garden & Pet Co
CENT
$2.71B
$2.54M ﹤0.01%
65,414
-54,281
-45% -$2.02M
ASHR icon
1316
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.57B
$2.54M ﹤0.01%
+95,826
New +$2.67M
CENTA icon
1317
Central Garden & Pet Co Class A
CENTA
$2.39B
$2.53M ﹤0.01%
76,524
+31,302
+69% +$997K
GSM icon
1318
FerroAtlántica
GSM
$617M
$2.51M ﹤0.01%
659,563
+623,363
+1,722% +$2.67M
ATKR icon
1319
Atkore
ATKR
$2.54B
$2.5M ﹤0.01%
30,004
-91,988
-75% -$8.11M
CWH icon
1320
Camping World
CWH
$389M
$2.5M ﹤0.01%
118,543
+77,710
+190% +$1.77M
PATK icon
1321
Patrick Industries
PATK
$2.81B
$2.5M ﹤0.01%
30,051
+25,851
+616% +$2.31M
PMTS icon
1322
CPI Card Group
PMTS
$235M
$2.48M ﹤0.01%
82,877
+43,814
+112% +$1.22M
BOW
1323
Bowhead Specialty Holdings
BOW
$1.02B
$2.47M ﹤0.01%
69,632
+46,257
+198% +$1.52M
HCSG icon
1324
Healthcare Services Group
HCSG
$1.58B
$2.46M ﹤0.01%
211,477
-242,914
-53% -$2.77M
VEON icon
1325
VEON
VEON
$3.58B
$2.45M ﹤0.01%
61,001

Similar funds

Marshall Wace's Q4 2024 Portfolio in Review

As of Q4 2024, Marshall Wace held 3,151 positions worth $83.2B, up 1.3% from $82.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Marshall Wace's Q4 2024 filing shows 709 new, 920 increased, 837 reduced and 626 closed positions. Its largest new stake was Boeing: 1,988,038 shares worth $352M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.09B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Marshall Wace's largest Q4 2024 buy was Boeing: 1,988,038 shares worth $352M.
  • Marshall Wace added most to Apple in Q4 2024, an estimated $1.06B increase.
  • Marshall Wace's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.09B.
  • Marshall Wace fully exited GE Vernova in Q4 2024, selling an estimated $439M.
  • Marshall Wace's ten largest holdings make up 35% of its $83.2B portfolio in Q4 2024.
  • Marshall Wace opened 709 new positions and closed 626 in Q4 2024.
  • Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $83.2B.

Based on Marshall Wace's 13F filing for Q4 2024, filed 13 Feb 2025.